Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-01-04 @ 8:46 AM
Study NCT ID:
NCT04693533
Status:
RECRUITING
Last Update Posted:
2025-01-22
First Post:
2020-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fremanezumab, Migraine and Sleep
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020P-001191
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |